Many experimental fmdings suggest that disturb ances of noradrenergic neurons in the CNS are involved in the pathogenesis ofdepressive disorders. Moreover, evidence indicates that adaptive changes of central noradrenergic neurons contribute to the biochemical mechanism of action of most anti depressive treatments (Goodwin, 1984; Johnstone, 1982). Accordingly, assessing the activity of central noradrenergic neurons in depressive patients has become important in psychiatric research.
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One ofthe most commonly used strategies for this task is determination ofthe norepmephrine metabo lite 3-methoxy-4-hydroxy-phenylethylene glycol (MHPG) in urine or plasma, assuming that the major part of MHPG in both body fluids is of central origin (Mass et al, 1979) . However, in a series of recent publications, Kopin et al have presented strong evidence that only about 20% of urinary MHPG originates from the CNS (Blom berry et al, 1980; Kopm et ci, 1984a) . These authors have seriously questioned the significance of urinary MHPG as a biochemical marker of central noradrenergic functions (Kopm et al, 1984a, b) . They propose the determination of plasma MHPG levels as the â€oe¿ best single overall index of norepinephrine metabolic rate available from examination of plasmaâ€• (Kopin et al, 1984b) .
While both these conclusions can be accepted, it should be stressed that they are easily misinterpreted by assuming that the determination of MHPG from the plasma is a much more reliable parameter than the determination from urine for assessing central noradrenergic functions. This is not the case: deter minations of MHPG in urine or in plasma respec tively are of similar value.
The important differences between the calcula tions of Maas et al and of Kopin et al are summar ised in the Table. By measuring the jugular veno arterial differences in MHPG concentrations, Maas et al, (1979) found that the brain releases about 41 gag/h of MHPG into the plasma, while the total urinary excretion rate was about 65 pig/h. Assuming that all plasma MHPG is excreted in the urine, either free or conjugated, they calculated that about 63% of urinary MHPG originates from the CNS and only 37% from peripheral organs. Using the same assumptions, a similar distribution should be present in the plasma.
However, Kopin's group were able to demon strate that about 70% of free plasma MHPG is further metabolised mainly to vanillyl mandelic acid (VMA) and that only 30% appears free or con jugated in the urine (Table) . Thus, if only 30% of the 41 gag/h which originate from CNS appears in the urine, central MHPG contributes only as little as 12 gag/h to the total urinary excretion rate of 65 gag/h, the central contribution to the urinary excretion of MHPG is therefore only about 19%, while 81% or 53 gAg/hof the urinary MHPG excre tion is of peripheral origin. Moreover, if only 30% of plasma MHPG appears in the urine, the urinary excretion rate of 65 gag/h will be only 30% of the total turnover rate offree MHPG in the plasma. The total turnover rate of free MHPG in the plasma can be calculated as about 216 gag/h ( = 100%). This value, calculated by us on the basis of the experi mental data given in the (1) 19Â¾ (4)Peripheral24 (4) 37Â¾ (1)175 (4) 81Â¾ (4)Total65 (4) 19Â¾ (2)Peripheral24 (4) 37Â¾ (1)53 (4) 81Â¾ (2)Total65 (1) 100Â¾ (1)65 (1) 100Â¾ (2) 96 COMMENT
TABLE
Turnover rates of plasma and urinary MHPG in healthy man in pg/h on the basis of the differentassumptionsof Maas and co-workers(left) and Kopin and co-workers (right) . Only the turnover rates indicated by an asterix () have been experimentally determined. All other turnover rates were calculated on the basis of thetwogivenassumptions andtheexperimentally determined turnover rates. MHPG is as high as 80%. Both determinations serve more as an overall parameter of noradrenergic function than as a specific indicator of the activity of central noradrenergic neurons (Kopin et a!, 1984a, b) . This is also the case in acute stimulation experiments, e.g. the clonidine test (Charney et a!, and might be less than the 70% originally deter mined by Blomberry et a!, (1979) (see Kopin et a!, 19Mb 
